ENVECSI
Live / Applied — Fourth extension granted (statement of use) (as of 18 Sept 2025)
What this means for you
Not registered yet, but its 17 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97463189
- Mark type
- Stylized text
- Filed
- 17 Jun 2022
- Published for opposition
- 08 Aug 2023
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines
Owner
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
Prosecution history
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2025 — SOU EXTENSION 4 GRANTED
- 18 Sept 2025 — SOU EXTENSION 4 FILED
- 18 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2025 — SOU EXTENSION 3 GRANTED
- 27 Mar 2025 — SOU EXTENSION 3 FILED
- 27 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Sept 2024 — SOU EXTENSION 2 GRANTED
- 26 Sept 2024 — SOU EXTENSION 2 FILED
- 26 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2024 — SOU EXTENSION 1 GRANTED